ZERO WORLD RESEARCHLiterature database on amino acids & organic acids

L-citrulline, Arginase Activity, and Nitrate As Potential Nitric Oxide-Related Markers of Subclinical Atherosclerosis in Healthy Middle-Aged Non-smokers: A Cross-Sectional Study.

Cureus2025Ogino N, Ogino K, Nogimura D, et al.
Study designOther primary literature
SubjectUnknown

Record checks

Study design
Other primary literature
Subject
Unknown
Publication year
2025
Source
doi.org
Abstract display
Shown here
Publication status
Active
Status checked
17 Aug 2026
Collected
3 Aug 2026
Freshness
Current
Review stage
Automated
Record status
Published

Abstract

Alterations in circulating nitric oxide (NO)-related factors, which play a key role in maintaining endothelial function, are thought to precede the development of atherosclerosis. These factors are also relatively modifiable through diet and supplements. Therefore, this cross-sectional exploratory study aimed to identify blood NO-related factors associated with the risk of subclinical atherosclerosis in 124 healthy, treatment-naïve, non-smoking individuals aged 45-70 years. As a result, significant associations were observed between brachial-ankle pulse wave velocity (PWV), an indicator of arterial stiffness, and circulating levels of L-citrulline, arginase activity, and nitrate (NO3 -). Specifically, circulating L-citrulline showed a negative association with PWV in non-drinkers (p = 0.007, β = -0.222). Arginase activity was positively associated with PWV among participants with a body mass index (BMI) ≤ 23 (p = 0.011, β = 0.196). Furthermore, plasma NO3 - levels exhibited a negative association with PWV in drinkers (p = 0.001, β = -0.274) and a positive association in non-drinkers (p = 0.005, β = 0.241). In conclusion, L-citrulline, arginase activity, and plasma NO3 - are potential markers of early vascular changes within subgroups of healthy middle-aged adults and may serve as targets for preventive medical approaches using diet or supplementation.

DOI 10.7759/cureus.91720

PMID 41058823

View source →